We have litigated in a pharmaceutical case concerning the validity of marketing authorisations.
Updates
Explore our latest insights, regulatory updates, and strategic reports for the life sciences sector.
Type
Sectors (2)
Expertises
27 results
Newest first
We regularly assist clients with pricing and reimbursement procedures in the Netherlands.
We have advised a large pharmaceutical company on the conduct of combined studies in collaboration with IVD manufacturers.
We have negotiated clinical trial agreements on behalf of several sponsors.
We have advised pharmaceutical companies with legal advice across the full product lifecycle, from early-stage development through to market authorisation and post-marketing compliance.
We have guided several clients through notified body interactions and discussions with competent authorities on product classification.
We have advised a laboratory on the regulatory status of laboratory developed tests (LDTs) under the IVDR.
We have assisted a diagnostics company with its companion diagnostics strategy, including the regulatory implications of combining diagnostic and therapeutic products.
We have advised an IVD manufacturer on a bringing companion diagnostic to market with respect to a patient support program.
Our team has advised an IVD-manufacturer on use of the inhouse-exemption under the IVDR.